Exploring Optimizing Treatment Approaches For Hepatocellular Carcinoma
Exploring Optimizing Treatment Approaches For Hepatocellular Carcinoma reveals several interesting facts.
- A key opinion leader comments on the sequencing of second-line therapies with regard to payers, and discusses where ...
- Richard S. Finn, MD, and Anthony El-Khoueiry, MD, discuss changes to the
- An in-depth analysis of data supporting lenvatinib versus sorafenib for the
- Changhoon Yoo, MD, PhD, Asan Medical Center, Seoul, Republic of Korea, describes current areas of unmet need in ...
- Join the Oncology Brothers, Drs. Rahul and Rohit Gosain, in this engaging podcast episode as they delve into the
In-Depth Information on Optimizing Treatment Approaches For Hepatocellular Carcinoma
David J. Pinato, MD, PhD, clinical senior lecturer in medical oncology, clinician scientist, consultant medical oncologist, ... Richard S. Finn, MD, Robin K. (“Katie”) Kelley, MD, and Laura M. Kulik, MD, discuss HCC in this CME/MOC activity titled "Patient ... This video is part of the HMP Education content archive and may include previously accredited educational material. While this ... Experts discuss
Chair, Richard S. Finn, MD, Ahmed Omar Kaseb, MD, CMQ, and Stacey M. Stein, MD, discuss HCC in this CME/MOC activity titled ...
Stay tuned for more updates related to Optimizing Treatment Approaches For Hepatocellular Carcinoma.
